World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03348709
Date of registration: 16/11/2017
Prospective Registration: No
Primary sponsor: University of Aarhus
Public title: Osmolality of Oral Supplements and Ileostomy Output
Scientific title: Does Osmolality of Oral Supplements Affect Stoma Output and Natriuresis in Patients With an Ileostomy?
Date of first enrolment: June 1, 2017
Target sample size: 8
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03348709
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Hendrik Vilstrup, Professor
Address: 
Telephone:
Email:
Affiliation:  University of Aarhus
Key inclusion & exclusion criteria

Inclusion Criteria:

- age 18 years or more

- ilestomy established 6 weeks or more prior to inclusion

- able to drink at least 100 ml fluid per 24 hours

- i known inflammatory bowel disease, clinical remission judged by physician's global
assessment (PGA)

- less than 5 kg self-reported weight change during the past 3 months

Exclusion Criteria:

- self-reported intolerance to dairy products, including lactose

- known renal insufficiency, defined by an eGFR less than 30 ml/min

- known diabetes mellitus, defined by an HbA1C > 48 mmol/mol (6.5%)

- current enteral tube feeding or parenteral fluid or Nutrition support more than twice
weekly



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Ileostomy - Stoma
Nutritional Deficiency
Short Bowel Syndrome
Sodium Depletion
Intervention(s)
Dietary Supplement: Hyperosmolar
Dietary Supplement: Isoosmolar
Primary Outcome(s)
Stoma output [Time Frame: 24 hours]
Secondary Outcome(s)
24-hour urinary sodium excretion [Time Frame: 24 hours]
24-hour urine production [Time Frame: 24 hours]
Secondary ID(s)
1-10-72-12-17
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Copenhagen
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history